Creating First-in-Class Antibody Drug Candidates

to meet Urgent Unmet Medical Need



MedAbome, Inc. is a biopharmaceutical discovery company located in San Francisco Bay Area (Fremont, California). We focus on the discovery and development of innovative therapeutic monoclonal antibodies (mAbs) and immunotherapy technologies for the treatment of major human cancer and non-cancer diseases, such as cancers (AML, gastric cancer, TNBC, pancreatic cancer, etc.), infectious diseases, inflammatory and autoimmune diseases, etc. By utilizing a combination of high-throughput (HT) hybridoma generation and live-cell high-throughput screening (LC-HTS) technologies, we are creating First-in-Class (FIC) therapeutic antibody candidates to meet the urgent demands of the patients and the global healthcare markets.




Copyright © 2016 MedAbome, Inc. - All Rights Reserved.